Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
c-Met in Human Malignancy c-Met overexpression, mutation, or aberrant activation occurs in a wide spectrum of human cancers, including: Gastric cancer Lung cancer (particularly non-small-cell lung cancer) Hepatocellular carcinoma Renal cell carcinoma Breast cancer Glioblastoma and other CNS tumours Colorectal cancer In these contexts, c-Met activation promotes tumour growth, metastasis, and drug resistance
Explore all our GLP-1 Solutions 100% online visit + checkout 1:1 expert care Clinically-backed Simple, achievable results You're a few clicks away from MIC + B12 Generally, yesespecially when administered under medical supervision
SELECT Trial Investigators
Its whether your body is supported to make and recycle it efficiently
